rs2074913

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_005219.5(DIAPH1):​c.117+14C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.068 in 1,532,352 control chromosomes in the GnomAD database, including 4,097 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.058 ( 359 hom., cov: 32)
Exomes 𝑓: 0.069 ( 3738 hom. )

Consequence

DIAPH1
NM_005219.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.88

Publications

7 publications found
Variant links:
Genes affected
DIAPH1 (HGNC:2876): (diaphanous related formin 1) This gene is a homolog of the Drosophila diaphanous gene, and has been linked to autosomal dominant, fully penetrant, nonsyndromic sensorineural progressive low-frequency hearing loss. Actin polymerization involves proteins known to interact with diaphanous protein in Drosophila and mouse. It has therefore been speculated that this gene may have a role in the regulation of actin polymerization in hair cells of the inner ear. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
DIAPH1 Gene-Disease associations (from GenCC):
  • DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • autosomal dominant nonsyndromic hearing loss 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
  • progressive microcephaly-seizures-cortical blindness-developmental delay syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 5-141618784-G-A is Benign according to our data. Variant chr5-141618784-G-A is described in ClinVar as Benign. ClinVar VariationId is 45212.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0773 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DIAPH1NM_005219.5 linkc.117+14C>T intron_variant Intron 1 of 27 ENST00000389054.8 NP_005210.3 O60610-1Q6URC4
DIAPH1NM_001079812.3 linkc.117+14C>T intron_variant Intron 1 of 26 NP_001073280.1
DIAPH1NM_001314007.2 linkc.117+14C>T intron_variant Intron 1 of 28 NP_001300936.1 A0A2R8Y5N1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DIAPH1ENST00000389054.8 linkc.117+14C>T intron_variant Intron 1 of 27 5 NM_005219.5 ENSP00000373706.4 O60610-1
DIAPH1ENST00000518047.5 linkc.117+14C>T intron_variant Intron 1 of 26 5 ENSP00000428268.2 O60610-3
DIAPH1ENST00000647433.1 linkc.117+14C>T intron_variant Intron 1 of 28 ENSP00000494675.1 A0A2R8Y5N1
DIAPH1ENST00000523100.5 linkn.117+14C>T intron_variant Intron 1 of 10 5 ENSP00000428208.1 B4E2I7

Frequencies

GnomAD3 genomes
AF:
0.0576
AC:
8764
AN:
152134
Hom.:
361
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0126
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.0366
Gnomad ASJ
AF:
0.0907
Gnomad EAS
AF:
0.0432
Gnomad SAS
AF:
0.0500
Gnomad FIN
AF:
0.124
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.0791
Gnomad OTH
AF:
0.0755
GnomAD2 exomes
AF:
0.0627
AC:
10183
AN:
162482
AF XY:
0.0624
show subpopulations
Gnomad AFR exome
AF:
0.0105
Gnomad AMR exome
AF:
0.0291
Gnomad ASJ exome
AF:
0.0834
Gnomad EAS exome
AF:
0.0407
Gnomad FIN exome
AF:
0.125
Gnomad NFE exome
AF:
0.0721
Gnomad OTH exome
AF:
0.0647
GnomAD4 exome
AF:
0.0691
AC:
95427
AN:
1380102
Hom.:
3738
Cov.:
25
AF XY:
0.0691
AC XY:
47246
AN XY:
683928
show subpopulations
African (AFR)
AF:
0.0112
AC:
346
AN:
30906
American (AMR)
AF:
0.0317
AC:
1178
AN:
37142
Ashkenazi Jewish (ASJ)
AF:
0.0824
AC:
2048
AN:
24854
East Asian (EAS)
AF:
0.0271
AC:
972
AN:
35810
South Asian (SAS)
AF:
0.0515
AC:
4046
AN:
78586
European-Finnish (FIN)
AF:
0.121
AC:
6010
AN:
49648
Middle Eastern (MID)
AF:
0.0764
AC:
423
AN:
5538
European-Non Finnish (NFE)
AF:
0.0722
AC:
76521
AN:
1060302
Other (OTH)
AF:
0.0677
AC:
3883
AN:
57316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
4231
8463
12694
16926
21157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2720
5440
8160
10880
13600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0576
AC:
8767
AN:
152250
Hom.:
359
Cov.:
32
AF XY:
0.0588
AC XY:
4377
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.0126
AC:
524
AN:
41564
American (AMR)
AF:
0.0366
AC:
560
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0907
AC:
315
AN:
3472
East Asian (EAS)
AF:
0.0436
AC:
225
AN:
5166
South Asian (SAS)
AF:
0.0499
AC:
241
AN:
4834
European-Finnish (FIN)
AF:
0.124
AC:
1321
AN:
10614
Middle Eastern (MID)
AF:
0.0884
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
0.0791
AC:
5376
AN:
67978
Other (OTH)
AF:
0.0776
AC:
164
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
420
840
1259
1679
2099
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0710
Hom.:
125
Bravo
AF:
0.0477
Asia WGS
AF:
0.0860
AC:
297
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jan 25, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

117+14C>T in Intron 01 of DIAPH1: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus seq uence and has been identified in 7.3% (459/6300) of European American chromosome s from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.w ashington.edu/EVS; dbSNP rs2074913). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant nonsyndromic hearing loss 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
Jul 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant nonsyndromic hearing loss 1;C5567650:Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
19
DANN
Benign
0.88
PhyloP100
1.9
PromoterAI
-0.030
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2074913; hg19: chr5-140998351; API